KRISTEN KEENE: Open Payments
NPI 1811675184 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 92 payments from 11 companies in 2025. Trend: 2023 $225 · 2024 $1,540 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $426 |
| E.R. Squibb & Sons, L.L.C. | 11 | $168 |
| Vanda Pharmaceuticals Inc. | 8 | $166 |
| Neurocrine BioSciences, Inc. | 8 | $166 |
| Otsuka America Pharmaceutical, Inc. | 8 | $158 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| HARMONY BIOSCIENCES LLC | 2 | $49 |
| Lundbeck LLC | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: VRAYLAR, REXULTI, COBENFY, HETLIOZ, INGREZZA, SPRAVATO, WAKIX, ABILIFY MAINTENA.
Industry payments across NC — which companies pay providers there.
